arrow
E

Enrico Patrucco

University of Torino
H指数:18
被引数:2,081

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FAK inhibitor and RAF/MEK clamp avutometinib enhance KRAS G12C inhibitor efficacy in preclinical models of non–small cell lung cancer

FAK抑制剂和RAF/MEK夹具avutometinib增强KRAS G12C抑制剂在非小细胞肺癌预临床模型中的疗效

2026-09-300
PRE
Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma (vol 25, pg 130, 2019)

Wiskott-Aldrich综合征蛋白(WASP)是T细胞淋巴瘤中的肿瘤抑制因子(卷25,页130,2019)

2026-03-010
PRE
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD

SOS1抑制剂BI-3406显示出类似基因敲除的在体抗肿瘤活性,并能与KRASG12D抑制剂协同作用,用于KRAS LUAD。

2025-03-120
OA
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
2023-07-1021
PRE
Targeting CCR7-PI3K? overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
2023-06-286
PRE
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
2022-12-013
OA
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer
2022-01-2826
OA
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma
2021-12-086
OA
Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma
2018-12-0357
OAAI